SlideShare a Scribd company logo
1 of 17
Download to read offline
1
1Q14 Results Presentation
São Paulo, May 16 2014
2
Agenda
Financial Results 1Q14
Capital Market Performance
3
46.5 40.7
143.7 168.1
38.8
38.25.1
5.3
1Q13 1Q14
Construction O&M Financial Others
234.1
252.3
Gross Operating Revenue
Company Consolidated(R$ million)
24.5
37.7
139.1
163.0
27.0
19.5
5.3
6.1
1Q13 1Q14
Construction O&M Financial Others
195.9
226.3
Growth of 17%in operating and maintenance revenue
+15.5% +7.8%
4
Net Operating Revenue
(R$ million)
Reduction of 18.8% on the deductions from revenue
166.3
200.2
34.5
25.1
1Q13 1Q14
Company Subsidiaries
200.8
225.3
+12.2%
5
Costs of Construction Services, O&M and
Operating Expenses
Company Consolidado
-24.1%
*
* Includes contingencies, depreciation and lease rentals
(R$ million)
-69.2
-56.6
-20.0
-10.3
-43.0
-36.9
-22.9
-24.8
1Q13 1Q14
Personnel Material Services Others
-155.1
-128.5
-71.0
-59.0
-41.7
-14.7
-45.1
-38.5
-23.2
-25.3
1Q13 1Q14
Personnel Material Services Others
-181.0
-137.4
**
Reduction of 64.7% in material and 14.6% in third party services
-17.2%
6
Ebitda ICVM 527 and Ebitda Margin
(R$ million)
28.4%
46.9%
51.6
103.05.4
2.6
1Q13 1Q14
Company Subsidiaries
56.9
105.6
Ebitda Margin
7
Equity
(R$ million)
1Q13
1Q14
20.8
19.9
0.6 0.2 0.2
IEMAD IEGAR IENNE IESUL TOTAL
0.0
15.2
12.2
3.5 (0,6)
0.1
IEMAD IEGAR IENNE IESUL TOTAL
Startup of Lot D of IEMadeira and advancement in the works of
IEGaranhuns
8
43.6
14.1
-4.6 -4.2
9.9
Company Subsidiaries
39.0
9.9
1Q13 1Q14
Financial Result
-74.6%
(R$ million)
Lower interest income on the NI
9
71.0
85.5
1Q13 1Q14
Net Income
+20.4%
(R$ million)
10
Net Debt
(*) As from January 2013, the Company’s financial investments have been concentrated in exclusive
investment funds. These are made up of highly liquid investment fund units, readily convertible into
cash, irrespective of the maturity of the assets.
Debt 1,337.7 1,239.5 7.9%
Short-term Debt 383.7 377.7 1.6%
Long-term Debt 954.0 861.8 10.7%
Cash* 502.2 600.0 -16.3%
Net Debt 835.5 639.5 30.7%
Debt
(BRLm)
1Q14 2013 Δ%
Funding BNDES of R $ 124.1 million
11
Debt
Distribuition of contracting Interest Rate
1Q14
2013
1Q14
2013
40.2%
59.5%
0.3%
40.2%
53.4%
6.1%
0.3%
TJLP CDI IPCA OthersBNDES Debentures Banks Others
43.2%
56.5%
0.2%
32.8%
50.7%
5.9%
10.6%
Debt R$ 1,337.7 million
12
Debt amortization
(R$ million)
305.6
101.5
199.83 199.9
181.8
11.1
49.8
21.1
29.9
30.9
26.5 26.5
26.5
85.4
15.0
335.4
132.4
226.3 226.4 208.3
37.6
2014 2015 2016 2017 2018 2019 2020 a 2024 2025 a 2029
CTEEP Subsidiaries
135.2
Future Cash (NI) 2014 2015 Total
Accounts Receivable (NI) - (projection) 427.1 332.2 759.3
Interest Income on the Accounts
Receivable (projection)
46.2 12.0 58.2
Total 473.3 344.2 817.5
Cash and Financial Investments on 03/31/14: R$ 502.2 millions
13
Debt - Jointly Owned Companies
Madeira Garanhuns IENNE IESUL
CTEEP Participation
2013 1Q14
(R$ million)
1,245.1
101.2
57.9 18.9
1,256.0
118.3
57.8 18.8
Debt: R$ 1,423.2
Debt: R$ 1.451,0
14
Agenda
Financial Results 1Q14
Capital Market Performance
15
Capital Market Performance
Total Trade: 87,5 mil
Daily Average/Day1,366
Market Value
03/31/2014 R$5,2billion
Share Performance until 03/31/2014
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
Jan-14 Feb-14 Mar-14
Trade Financial - 03/31/2014
(R$ million)
Total R$ 549 Million Daily Average / Day R$ 8.6 million
70.00
100.00
Jan-14 Feb-14 Mar-14
TRPL3 TRPL4 IBOVESPA IEE
-5.38%
-2.12%
-8.51%
3.86%
(base 12/31/2013 = 100)
16
Disclaimer
All statements contained herein with regard to the Company’s
business prospects, projected results and the potential growth
of its business aremere forecasts, based on local management
expectationsin relation to the Company’s future performance.
Dependent as they are on market shifts and on the overall
performance of the Brazilian economy and the sector
and international markets, such estimates
are subject to changes.
17
Investor Relations
Tel: +55 11 3138-7557
ri@cteep.com.br
www.cteep.com.br/ri

More Related Content

What's hot (8)

Webcast 3q17 ing final
Webcast 3q17 ing finalWebcast 3q17 ing final
Webcast 3q17 ing final
 
1Q09 analyst meeting
1Q09 analyst meeting1Q09 analyst meeting
1Q09 analyst meeting
 
Webcast 1Q09 Eng
Webcast 1Q09 EngWebcast 1Q09 Eng
Webcast 1Q09 Eng
 
Nordnet Q4 2011 presentation
Nordnet Q4 2011 presentationNordnet Q4 2011 presentation
Nordnet Q4 2011 presentation
 
Webcast 2Q14 and 1H14
Webcast 2Q14 and 1H14Webcast 2Q14 and 1H14
Webcast 2Q14 and 1H14
 
Apresentação call tiete 3 q13_eng_final
Apresentação call tiete 3 q13_eng_finalApresentação call tiete 3 q13_eng_final
Apresentação call tiete 3 q13_eng_final
 
Webcast 4 t14 ing
Webcast 4 t14 ingWebcast 4 t14 ing
Webcast 4 t14 ing
 
Allianz: Group Financial Results 2013
Allianz: Group Financial Results 2013Allianz: Group Financial Results 2013
Allianz: Group Financial Results 2013
 

Viewers also liked

Apimec ing
Apimec ingApimec ing
Apimec ing
Cteep
 
Cteep apresentacao 2_q10_16august2010_english
Cteep apresentacao 2_q10_16august2010_englishCteep apresentacao 2_q10_16august2010_english
Cteep apresentacao 2_q10_16august2010_english
Cteep
 
19 apimec
19   apimec19   apimec
19 apimec
Cteep
 
Apresentacao 4 t11_ingl
Apresentacao 4 t11_inglApresentacao 4 t11_ingl
Apresentacao 4 t11_ingl
Cteep
 
Presentation 4Q12
Presentation 4Q12Presentation 4Q12
Presentation 4Q12
Cteep
 
Apimec 2014 ing
Apimec 2014 ingApimec 2014 ing
Apimec 2014 ing
Cteep
 
1 presentation 1 q11
1   presentation 1 q111   presentation 1 q11
1 presentation 1 q11
Cteep
 
2011 08-15 cteep-release_2_q11
2011 08-15 cteep-release_2_q112011 08-15 cteep-release_2_q11
2011 08-15 cteep-release_2_q11
Cteep
 
Presentation 2Q12
Presentation 2Q12Presentation 2Q12
Presentation 2Q12
Cteep
 
Presentation 3Q12
Presentation 3Q12Presentation 3Q12
Presentation 3Q12
Cteep
 
Cteep presentation 2_q11
Cteep presentation 2_q11Cteep presentation 2_q11
Cteep presentation 2_q11
Cteep
 
1q10
1q101q10
1q10
Cteep
 
6 transmissão paulista february 20 2008
6   transmissão paulista february 20 20086   transmissão paulista february 20 2008
6 transmissão paulista february 20 2008
Cteep
 
Cteep presentation 1_q11
Cteep presentation 1_q11Cteep presentation 1_q11
Cteep presentation 1_q11
Cteep
 
2009 11-16 cteep-presentation_3_q09
2009 11-16 cteep-presentation_3_q092009 11-16 cteep-presentation_3_q09
2009 11-16 cteep-presentation_3_q09
Cteep
 
Cteep release 3_q11
Cteep release 3_q11Cteep release 3_q11
Cteep release 3_q11
Cteep
 
Cteep presentation 2_q09
Cteep presentation 2_q09Cteep presentation 2_q09
Cteep presentation 2_q09
Cteep
 
Presentation 1Q12
Presentation 1Q12Presentation 1Q12
Presentation 1Q12
Cteep
 
5 2 q09 results presentation
5   2 q09 results presentation5   2 q09 results presentation
5 2 q09 results presentation
Cteep
 

Viewers also liked (19)

Apimec ing
Apimec ingApimec ing
Apimec ing
 
Cteep apresentacao 2_q10_16august2010_english
Cteep apresentacao 2_q10_16august2010_englishCteep apresentacao 2_q10_16august2010_english
Cteep apresentacao 2_q10_16august2010_english
 
19 apimec
19   apimec19   apimec
19 apimec
 
Apresentacao 4 t11_ingl
Apresentacao 4 t11_inglApresentacao 4 t11_ingl
Apresentacao 4 t11_ingl
 
Presentation 4Q12
Presentation 4Q12Presentation 4Q12
Presentation 4Q12
 
Apimec 2014 ing
Apimec 2014 ingApimec 2014 ing
Apimec 2014 ing
 
1 presentation 1 q11
1   presentation 1 q111   presentation 1 q11
1 presentation 1 q11
 
2011 08-15 cteep-release_2_q11
2011 08-15 cteep-release_2_q112011 08-15 cteep-release_2_q11
2011 08-15 cteep-release_2_q11
 
Presentation 2Q12
Presentation 2Q12Presentation 2Q12
Presentation 2Q12
 
Presentation 3Q12
Presentation 3Q12Presentation 3Q12
Presentation 3Q12
 
Cteep presentation 2_q11
Cteep presentation 2_q11Cteep presentation 2_q11
Cteep presentation 2_q11
 
1q10
1q101q10
1q10
 
6 transmissão paulista february 20 2008
6   transmissão paulista february 20 20086   transmissão paulista february 20 2008
6 transmissão paulista february 20 2008
 
Cteep presentation 1_q11
Cteep presentation 1_q11Cteep presentation 1_q11
Cteep presentation 1_q11
 
2009 11-16 cteep-presentation_3_q09
2009 11-16 cteep-presentation_3_q092009 11-16 cteep-presentation_3_q09
2009 11-16 cteep-presentation_3_q09
 
Cteep release 3_q11
Cteep release 3_q11Cteep release 3_q11
Cteep release 3_q11
 
Cteep presentation 2_q09
Cteep presentation 2_q09Cteep presentation 2_q09
Cteep presentation 2_q09
 
Presentation 1Q12
Presentation 1Q12Presentation 1Q12
Presentation 1Q12
 
5 2 q09 results presentation
5   2 q09 results presentation5   2 q09 results presentation
5 2 q09 results presentation
 

Similar to Cteep presentation 1_q14.

4 q07 conference call presentation
4 q07 conference call presentation4 q07 conference call presentation
4 q07 conference call presentation
BancoABCRI
 
Carolyn Fisher, FCF DDM Model UPDATED
Carolyn Fisher, FCF DDM Model UPDATEDCarolyn Fisher, FCF DDM Model UPDATED
Carolyn Fisher, FCF DDM Model UPDATED
Carrie Fisher
 

Similar to Cteep presentation 1_q14. (20)

Cteep Presentation 2Q14.
Cteep Presentation 2Q14.Cteep Presentation 2Q14.
Cteep Presentation 2Q14.
 
A9 r735e
A9 r735eA9 r735e
A9 r735e
 
PNB Analyst presentation Mar`22 (3).pdf
PNB Analyst presentation Mar`22 (3).pdfPNB Analyst presentation Mar`22 (3).pdf
PNB Analyst presentation Mar`22 (3).pdf
 
Monsanto company
Monsanto companyMonsanto company
Monsanto company
 
Interplex presentation results_q4_fy15
Interplex presentation results_q4_fy15Interplex presentation results_q4_fy15
Interplex presentation results_q4_fy15
 
Conference Call 3Q15
Conference Call 3Q15Conference Call 3Q15
Conference Call 3Q15
 
Conference Call 4Q15
Conference Call 4Q15Conference Call 4Q15
Conference Call 4Q15
 
2Q13 Disclosure and Results
2Q13 Disclosure and Results2Q13 Disclosure and Results
2Q13 Disclosure and Results
 
Excel Model of Trading Firm
Excel Model of Trading FirmExcel Model of Trading Firm
Excel Model of Trading Firm
 
Neslte India Ltd_Financial Model Working.pdf
Neslte India Ltd_Financial Model Working.pdfNeslte India Ltd_Financial Model Working.pdf
Neslte India Ltd_Financial Model Working.pdf
 
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold
 
4 q07 conference call presentation
4 q07 conference call presentation4 q07 conference call presentation
4 q07 conference call presentation
 
INVESTAURA_Business-Planning-Template.pdf
INVESTAURA_Business-Planning-Template.pdfINVESTAURA_Business-Planning-Template.pdf
INVESTAURA_Business-Planning-Template.pdf
 
Conference Call 2Q15
Conference Call 2Q15Conference Call 2Q15
Conference Call 2Q15
 
Carolyn Fisher, FCF DDM Model UPDATED
Carolyn Fisher, FCF DDM Model UPDATEDCarolyn Fisher, FCF DDM Model UPDATED
Carolyn Fisher, FCF DDM Model UPDATED
 
Shc 1 q16_pt_new_eng_f
Shc 1 q16_pt_new_eng_fShc 1 q16_pt_new_eng_f
Shc 1 q16_pt_new_eng_f
 
Corporate Presentation 1Q13
Corporate Presentation 1Q13Corporate Presentation 1Q13
Corporate Presentation 1Q13
 
Conference Call 4Q14
Conference Call 4Q14Conference Call 4Q14
Conference Call 4Q14
 
Analyst PPT Dec 22.pdf
Analyst PPT Dec 22.pdfAnalyst PPT Dec 22.pdf
Analyst PPT Dec 22.pdf
 
Conference Call 1Q16
 Conference Call 1Q16 Conference Call 1Q16
Conference Call 1Q16
 

More from Cteep

Composição acionária 3t14 en
Composição acionária 3t14 enComposição acionária 3t14 en
Composição acionária 3t14 en
Cteep
 
Cteep apresentação 1_t14
Cteep apresentação 1_t14Cteep apresentação 1_t14
Cteep apresentação 1_t14
Cteep
 
Apimec 2013 final
Apimec 2013 finalApimec 2013 final
Apimec 2013 final
Cteep
 
Apresentação 4T12
Apresentação 4T12 Apresentação 4T12
Apresentação 4T12
Cteep
 
Teleconferência 4 t12
Teleconferência 4 t12 Teleconferência 4 t12
Teleconferência 4 t12
Cteep
 
Teleconferência 4 t12
Teleconferência 4 t12 Teleconferência 4 t12
Teleconferência 4 t12
Cteep
 
APIMEC 2012
APIMEC 2012APIMEC 2012
APIMEC 2012
Cteep
 
Apresentação 3T12
Apresentação 3T12Apresentação 3T12
Apresentação 3T12
Cteep
 
Apresentação 3T12
Apresentação 3T12Apresentação 3T12
Apresentação 3T12
Cteep
 
Presentation 3Q12
Presentation 3Q12Presentation 3Q12
Presentation 3Q12
Cteep
 
Apresentação 2T12
Apresentação 2T12Apresentação 2T12
Apresentação 2T12
Cteep
 
Apresentação 1T12
Apresentação 1T12Apresentação 1T12
Apresentação 1T12
Cteep
 
Apresentacao 4 t11_port
Apresentacao 4 t11_portApresentacao 4 t11_port
Apresentacao 4 t11_port
Cteep
 
Cteep apresentação 1 t12_14maio2012(1)
Cteep apresentação 1 t12_14maio2012(1)Cteep apresentação 1 t12_14maio2012(1)
Cteep apresentação 1 t12_14maio2012(1)
Cteep
 
Cteep presentation 1 q12_may_14_2012
Cteep presentation 1 q12_may_14_2012Cteep presentation 1 q12_may_14_2012
Cteep presentation 1 q12_may_14_2012
Cteep
 
Presentation 4 q11
Presentation 4 q11Presentation 4 q11
Presentation 4 q11
Cteep
 
Apresentação 4 t11
Apresentação 4 t11Apresentação 4 t11
Apresentação 4 t11
Cteep
 
Cteep presentation 3_q11
Cteep presentation 3_q11Cteep presentation 3_q11
Cteep presentation 3_q11
Cteep
 
Cteep apresentacao 2_t11
Cteep apresentacao 2_t11Cteep apresentacao 2_t11
Cteep apresentacao 2_t11
Cteep
 
Cteep apresentacao 1_q09_v_21maio2009_english_final
Cteep apresentacao 1_q09_v_21maio2009_english_finalCteep apresentacao 1_q09_v_21maio2009_english_final
Cteep apresentacao 1_q09_v_21maio2009_english_final
Cteep
 

More from Cteep (20)

Composição acionária 3t14 en
Composição acionária 3t14 enComposição acionária 3t14 en
Composição acionária 3t14 en
 
Cteep apresentação 1_t14
Cteep apresentação 1_t14Cteep apresentação 1_t14
Cteep apresentação 1_t14
 
Apimec 2013 final
Apimec 2013 finalApimec 2013 final
Apimec 2013 final
 
Apresentação 4T12
Apresentação 4T12 Apresentação 4T12
Apresentação 4T12
 
Teleconferência 4 t12
Teleconferência 4 t12 Teleconferência 4 t12
Teleconferência 4 t12
 
Teleconferência 4 t12
Teleconferência 4 t12 Teleconferência 4 t12
Teleconferência 4 t12
 
APIMEC 2012
APIMEC 2012APIMEC 2012
APIMEC 2012
 
Apresentação 3T12
Apresentação 3T12Apresentação 3T12
Apresentação 3T12
 
Apresentação 3T12
Apresentação 3T12Apresentação 3T12
Apresentação 3T12
 
Presentation 3Q12
Presentation 3Q12Presentation 3Q12
Presentation 3Q12
 
Apresentação 2T12
Apresentação 2T12Apresentação 2T12
Apresentação 2T12
 
Apresentação 1T12
Apresentação 1T12Apresentação 1T12
Apresentação 1T12
 
Apresentacao 4 t11_port
Apresentacao 4 t11_portApresentacao 4 t11_port
Apresentacao 4 t11_port
 
Cteep apresentação 1 t12_14maio2012(1)
Cteep apresentação 1 t12_14maio2012(1)Cteep apresentação 1 t12_14maio2012(1)
Cteep apresentação 1 t12_14maio2012(1)
 
Cteep presentation 1 q12_may_14_2012
Cteep presentation 1 q12_may_14_2012Cteep presentation 1 q12_may_14_2012
Cteep presentation 1 q12_may_14_2012
 
Presentation 4 q11
Presentation 4 q11Presentation 4 q11
Presentation 4 q11
 
Apresentação 4 t11
Apresentação 4 t11Apresentação 4 t11
Apresentação 4 t11
 
Cteep presentation 3_q11
Cteep presentation 3_q11Cteep presentation 3_q11
Cteep presentation 3_q11
 
Cteep apresentacao 2_t11
Cteep apresentacao 2_t11Cteep apresentacao 2_t11
Cteep apresentacao 2_t11
 
Cteep apresentacao 1_q09_v_21maio2009_english_final
Cteep apresentacao 1_q09_v_21maio2009_english_finalCteep apresentacao 1_q09_v_21maio2009_english_final
Cteep apresentacao 1_q09_v_21maio2009_english_final
 

Recently uploaded

!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
DUBAI (+971)581248768 BUY ABORTION PILLS IN ABU dhabi...Qatar
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
daisycvs
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
Nauman Safdar
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
ZurliaSoop
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
laloo_007
 

Recently uploaded (20)

Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Arti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfArti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdf
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
 
Uneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration PresentationUneak White's Personal Brand Exploration Presentation
Uneak White's Personal Brand Exploration Presentation
 
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
Falcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business GrowthFalcon Invoice Discounting: Empowering Your Business Growth
Falcon Invoice Discounting: Empowering Your Business Growth
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024HomeRoots Pitch Deck | Investor Insights | April 2024
HomeRoots Pitch Deck | Investor Insights | April 2024
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
Cracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareCracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' Slideshare
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered  Building Manufacturers Hyderabad.pptxPre Engineered  Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
 
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai KuwaitThe Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
The Abortion pills for sale in Qatar@Doha [+27737758557] []Deira Dubai Kuwait
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
 

Cteep presentation 1_q14.

  • 1. 1 1Q14 Results Presentation São Paulo, May 16 2014
  • 3. 3 46.5 40.7 143.7 168.1 38.8 38.25.1 5.3 1Q13 1Q14 Construction O&M Financial Others 234.1 252.3 Gross Operating Revenue Company Consolidated(R$ million) 24.5 37.7 139.1 163.0 27.0 19.5 5.3 6.1 1Q13 1Q14 Construction O&M Financial Others 195.9 226.3 Growth of 17%in operating and maintenance revenue +15.5% +7.8%
  • 4. 4 Net Operating Revenue (R$ million) Reduction of 18.8% on the deductions from revenue 166.3 200.2 34.5 25.1 1Q13 1Q14 Company Subsidiaries 200.8 225.3 +12.2%
  • 5. 5 Costs of Construction Services, O&M and Operating Expenses Company Consolidado -24.1% * * Includes contingencies, depreciation and lease rentals (R$ million) -69.2 -56.6 -20.0 -10.3 -43.0 -36.9 -22.9 -24.8 1Q13 1Q14 Personnel Material Services Others -155.1 -128.5 -71.0 -59.0 -41.7 -14.7 -45.1 -38.5 -23.2 -25.3 1Q13 1Q14 Personnel Material Services Others -181.0 -137.4 ** Reduction of 64.7% in material and 14.6% in third party services -17.2%
  • 6. 6 Ebitda ICVM 527 and Ebitda Margin (R$ million) 28.4% 46.9% 51.6 103.05.4 2.6 1Q13 1Q14 Company Subsidiaries 56.9 105.6 Ebitda Margin
  • 7. 7 Equity (R$ million) 1Q13 1Q14 20.8 19.9 0.6 0.2 0.2 IEMAD IEGAR IENNE IESUL TOTAL 0.0 15.2 12.2 3.5 (0,6) 0.1 IEMAD IEGAR IENNE IESUL TOTAL Startup of Lot D of IEMadeira and advancement in the works of IEGaranhuns
  • 8. 8 43.6 14.1 -4.6 -4.2 9.9 Company Subsidiaries 39.0 9.9 1Q13 1Q14 Financial Result -74.6% (R$ million) Lower interest income on the NI
  • 10. 10 Net Debt (*) As from January 2013, the Company’s financial investments have been concentrated in exclusive investment funds. These are made up of highly liquid investment fund units, readily convertible into cash, irrespective of the maturity of the assets. Debt 1,337.7 1,239.5 7.9% Short-term Debt 383.7 377.7 1.6% Long-term Debt 954.0 861.8 10.7% Cash* 502.2 600.0 -16.3% Net Debt 835.5 639.5 30.7% Debt (BRLm) 1Q14 2013 Δ% Funding BNDES of R $ 124.1 million
  • 11. 11 Debt Distribuition of contracting Interest Rate 1Q14 2013 1Q14 2013 40.2% 59.5% 0.3% 40.2% 53.4% 6.1% 0.3% TJLP CDI IPCA OthersBNDES Debentures Banks Others 43.2% 56.5% 0.2% 32.8% 50.7% 5.9% 10.6% Debt R$ 1,337.7 million
  • 12. 12 Debt amortization (R$ million) 305.6 101.5 199.83 199.9 181.8 11.1 49.8 21.1 29.9 30.9 26.5 26.5 26.5 85.4 15.0 335.4 132.4 226.3 226.4 208.3 37.6 2014 2015 2016 2017 2018 2019 2020 a 2024 2025 a 2029 CTEEP Subsidiaries 135.2 Future Cash (NI) 2014 2015 Total Accounts Receivable (NI) - (projection) 427.1 332.2 759.3 Interest Income on the Accounts Receivable (projection) 46.2 12.0 58.2 Total 473.3 344.2 817.5 Cash and Financial Investments on 03/31/14: R$ 502.2 millions
  • 13. 13 Debt - Jointly Owned Companies Madeira Garanhuns IENNE IESUL CTEEP Participation 2013 1Q14 (R$ million) 1,245.1 101.2 57.9 18.9 1,256.0 118.3 57.8 18.8 Debt: R$ 1,423.2 Debt: R$ 1.451,0
  • 15. 15 Capital Market Performance Total Trade: 87,5 mil Daily Average/Day1,366 Market Value 03/31/2014 R$5,2billion Share Performance until 03/31/2014 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0 Jan-14 Feb-14 Mar-14 Trade Financial - 03/31/2014 (R$ million) Total R$ 549 Million Daily Average / Day R$ 8.6 million 70.00 100.00 Jan-14 Feb-14 Mar-14 TRPL3 TRPL4 IBOVESPA IEE -5.38% -2.12% -8.51% 3.86% (base 12/31/2013 = 100)
  • 16. 16 Disclaimer All statements contained herein with regard to the Company’s business prospects, projected results and the potential growth of its business aremere forecasts, based on local management expectationsin relation to the Company’s future performance. Dependent as they are on market shifts and on the overall performance of the Brazilian economy and the sector and international markets, such estimates are subject to changes.
  • 17. 17 Investor Relations Tel: +55 11 3138-7557 ri@cteep.com.br www.cteep.com.br/ri